Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

After a multiple sclerosis diagnosis, travel became nearly impossible for Selma Blair. At California’s iconic — and ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Follow-up treatments and regular monitoring are essential for ongoing symptom management. Botox is a valuable tool in the management of multiple sclerosis (MS), addressing key symptoms such as ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Having multiple sclerosis (MS) was associated with higher rates of mental illness during the peripartum period than not ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

A young woman has taken to social media to bring awareness to Multiple sclerosis, often shortened to 'MS' after having been ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.